[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368263-105":59,"doc-detail-368263-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","significant-association-of-matrix-metalloproteinase-9-polymorphisms-with-triple-negative-breast-cancer-risk","Significant Association of Matrix Metalloproteinase-9 Polymorphisms With Triple Negative Breast Cancer Risk","","Matrix metalloproteinase-9 (MMP-9) is implicated in breast cancer development and progression, yet genetic associations between MMP-9 variants and disease susceptibility remain unsettled. A case-control study assessed MMP-9 rs3918242 promoter polymorphisms in 1,232 breast cancer patients and 1,232 healthy controls using PCR-RFLP genotyping. No overall genotype or allele associations were found for breast cancer risk, and age-related interactions were absent. The TT genotype showed a significant increase in triple-negative breast cancer risk.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/significant-association-of-matrix-metalloproteinase-9-polymorphisms-with-triple-negative-breast-cancer-risk/368263/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/significant-association-of-matrix-metalloproteinase-9-polymorphisms-with-triple-negative-breast-cancer-risk/368263.png","ImageObject",300,407,{"name":92,"@type":93},"Ezra","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the goal of the study on MMP-9 and breast cancer?","Question",{"text":112,"@type":113},"To evaluate whether MMP-9 rs3918242 promoter polymorphisms are associated with breast cancer susceptibility, with emphasis on triple-negative breast cancer (TNBC).","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were MMP-9 rs3918242 genotypes measured?",{"text":117,"@type":113},"Genotypes were determined in a case-control design using PCR-RFLP analysis.",{"name":119,"@type":110,"acceptedAnswer":120},"Which MMP-9 genotype was linked to TNBC risk?",{"text":121,"@type":113},"The TT genotype of MMP-9 rs3918242 was significantly associated with increased TNBC risk (OR=2.49, p=0.0072).","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368263,1790654874,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","doi: 10.21873/cgp.20500  \nSignificant Association of Matrix Metalloproteinase‐9 Polymorphisms With Triple Negative Breast Cancer Risk  \nCHIH‐CHIANG HUNG1*, YUN‐CHI WANG2,3*, HOU‐YU SHIH2,3*, CHIA‐HUA LIU1, JIE‐LONG HE4,  \nJAW‐CHYUN CHEN5, WEN‐SHIN CHANG2,3, CHEN‐HSIEN SU3, DA‐TIAN BAU2,3,6 and CHIA‐WENTSAI2,3  \n1 Division of Breast Surgery, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.; 2Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.;  \n3Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.;  \n4 Department of Post‐Baccalaureate Veterinary Medicine, Asia University, Taichung, Taiwan, R.O.C.;  \n5 Department of Medicinal Botanicals and Foods on Health Applications, Da‐Yeh University, Changhua, Taiwan, R.O.C.; 6 Department of Bioinformatics and Medical Engineering, Asia University, Taichung, Taiwan, R.O.C.  \nAbstract  \nBackground/Aim: Matrix metalloproteinase‑9 (MMP‑9) has been associated with the development and progression of breast cancer (BCa) . However, the relationship between MMP‑9 genetic variants and BCa susceptibility remains contentious and inconclusive. This study aimed to evaluate the association of MMP‑9 rs3918242 promoter polymorphisms with BCa, with a particular focus on the risk of triple‑negative breast cancer (TNBC) .  \nMaterials and Methods: A case‑control study was conducted involving 1,232 BCa patients and 1,232 healthy controls. The MMP‑9 rs3918242 genotypes were determined using polymerase chain reaction‑restriction fragment length polymorphism (PCR‑RFLP) analysis.  \nResults: The genotype distribution of MMP‑9 rs3918242 among the control group adhered to Hardy‑Weinberg equilibrium (p=0.3265). No statistically significant differences were observed in the genotype frequencies between BCa cases and controls (p for trend=0.2555) . Although the homozygous variant genotype (TT) showed a potential risk‑increasing effect, this was not statistically significant [odds ratio (OR)=1.43, 95% confidence interval (CI)=0.88‑ 2.36, p=0.1869]. Similarly, allele frequency analysis indicated no significant association between the variant T allele and overall BCa risk (OR=1.13, 95%CI=0.97‑1.33, p=0.1265). Additionally, no interaction was detected between MMP‑ 9 rs3918242 genotypes and the age of BCa onset (both p>0.05). Notably, the TT genotype of MMP‑9 rs3918242 was significantly associated with an increased risk ofTNBC (OR=2.49, 95%CI=1.32‑4.72, p=0.0072) .  \n†These Authors contributed equally to this work.  \n✉  \nDa‑Tian Bau and Chia‑Wen Tsai, Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, 2 Yuh‑Der Road, Taichung, 404 Taiwan, R.O.C. Tel: +886 422053366 (Ext. 5805), e‑mail: [013280@tool.caaumed.org.tw](013280@tool.caaumed.org.tw) (Bau),  \n[017891@tool.caaumed.org.tw](017891@tool.caaumed.org.tw) (Tsai)  \nReceived August 9, 2024 | Revised October 7, 2024 | Accepted October 9, 2024  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n©2025 The Author(s) . Anticancer Research is published by the International Institute of Anticancer Research.  \nConclusion: The MMP‑9 rs3918242 TT genotype may serve as a potential predictive biomarker for TNBC in the Taiwanese population.  \nKeywords: Breast cancer, matrix metalloproteinase‑9, polymorphism, triple negative breast cancer, Taiwan.  \nIntroduction  \nBreast cancer (BCa) is the most prevalent malignancy among women in 157 out of 185 countries, leading to 670,000 deaths globally in 2022 (1, 2). There are several indexes, including age, obesity, smoking, alcohol consumption, high‑sugar diets, a sedentary lifestyle, and familial genetics, being recognized as BCa risk factors (3‑ 5) . Among the subtypes of BCa, triple‑negative ","cbCailFtmm11hC9c","https://ap.wps.com/l/cbCailFtmm11hC9c","pdf",931807,13,"English","# Abstract\n## Background/Aim\n## Materials and Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What was the goal of the study on MMP-9 and breast cancer?\",\"answer\":\"To evaluate whether MMP-9 rs3918242 promoter polymorphisms are associated with breast cancer susceptibility, with emphasis on triple-negative breast cancer (TNBC).\"},{\"question\":\"How were MMP-9 rs3918242 genotypes measured?\",\"answer\":\"Genotypes were determined in a case-control design using PCR-RFLP analysis.\"},{\"question\":\"Which MMP-9 genotype was linked to TNBC risk?\",\"answer\":\"The TT genotype of MMP-9 rs3918242 was significantly associated with increased TNBC risk (OR=2.49, p=0.0072).\"}]","Significant Association of Matrix Metalloproteinase-9 Polymorphisms With Triple Negative Breast Cancer Risk | PDF",1790175924,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6f4a3bbac25458c66b573cc89111ee19.webp",983,1301,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/158034998bfffdf27091fce040e9962c.webp",982,1299,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ebe367bb28d733115a504535c45f3513.webp",981,1298,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5c39d4d685be88b946bd45fc1c1d4b8d.webp",980,1297]